Patents Assigned to Enigma Therapeutics Limited
  • DEVICES AND METHODS FOR THE TREATMENT OF CANCER
    Publication number: 20140193335
    Abstract: The invention relates to the treatment of cancer. In particular the invention relates to an internal therapeutic product comprising: (i) an anti-cancer component selected from one or both of: a radionucleotide, a cytotoxic drug; and (ii) a silicon component selected from one or more of: resorbable silicon, biocompatible silicon, bioactive silicon, porous silicon, polycrystalline silicon, amorphous silicon, and bulk crystalline silicon, the internal therapeutic product being for the treatment of cancer.
    Type: Application
    Filed: January 8, 2014
    Publication date: July 10, 2014
    Applicant: ENIGMA THERAPEUTICS LIMITED
    Inventors: Roger ASTON, Leigh T. CANHAM
  • Devices and methods for the treatment of cancer
    Patent number: 8647603
    Abstract: The invention relates to the treatment of cancer. In particular the invention relates to an internal therapeutic product comprising: (i) an anti-cancer component selected from one or both of: a radionucleotide, a cytotoxic drug; and (ii) a silicon component selected from one or more of: resorbable silicon, biocompatible silicon, bioactive silicon, porous silicon, polycrystalline silicon, amorphous silicon, and bulk crystalline silicon, the internal therapeutic product being for the treatment of cancer.
    Type: Grant
    Filed: December 8, 2011
    Date of Patent: February 11, 2014
    Assignee: Enigma Therapeutics Limited
    Inventors: Roger Aston, Leigh Canham